Workability in severe asthma

  • Research type

    Research Study

  • Full title

    A qualitative study of the impact of bio-psychosocial and cultural factors on employment and work ability in patients with severe asthma

  • IRAS ID

    308678

  • Contact name

    Gareth Walters

  • Contact email

    Gareth.walters@uhb.nhs.uk

  • Sponsor organisation

    University of Birmingham

  • Duration of Study in the UK

    0 years, 7 months, 0 days

  • Research summary

    Severe asthma describes asthma that is symptomatic despite adherence to high levels of treatment and control of other trigger factors (eg. acid reflux, sleep apnoea). It is considered as a separate group to mild or moderate disease, since it has several distinct clinical phenotypes, and represents less than 5% of all asthma. Although about half of patients with severe asthma are employed, poor asthma control may lead to periods of sick leave (absenteeism) or disability at work (presenteeism), more so than for mild/moderate asthma. Poor physical health status and clinical depression have both been implicated as reasons for this, but the relationship has not been investigated in depth, and may only partly explain the excess of absenteeism and work disability. We have hypothesised that there may be a variety of other socio-demographic, psychological and cultural factors that impact on ability to work in severe asthma. In order to explore these factors further, we intend to undertake qualitative research comprising interviews with patients with severe asthma, according to a semi-structured interview schedule including questions relating to all factors above; we will include a mixture of patients who are employed and those who are not. Patients will be recruited from the Birmingham Regional Severe Asthma Service at Heartlands Hospital, where the researchers are also core clinical team members. We will undertake thematic analysis with the data, and aim to interview patients until there is saturation of themes. The study will be disseminated by presentation to the Severe Asthma Service (patients and staff), at a respiratory conference, and by publication in a peer-reviewed paper.

  • REC name

    London - Riverside Research Ethics Committee

  • REC reference

    22/PR/0096

  • Date of REC Opinion

    17 Feb 2022

  • REC opinion

    Further Information Favourable Opinion